Bausch Health Companies (BHC) Scheduled to Post Quarterly Earnings on Thursday

Bausch Health Companies (TSE:BHC) will be announcing its earnings results before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of C$1.01 per share for the quarter.

Bausch Health Companies (TSE:BHC) last announced its earnings results on Thursday, February 22nd. The company reported C$1.55 EPS for the quarter, beating analysts’ consensus estimates of C$1.36 by C$0.19. The business had revenue of C$3.28 billion for the quarter, compared to analysts’ expectations of C$3.05 billion. Bausch Health Companies had a negative net margin of 6.76% and a negative return on equity of 686.52%.

Bausch Health Companies Stock Performance

TSE BHC traded up C$0.14 during trading on Tuesday, reaching C$12.27. The company’s stock had a trading volume of 43,353 shares, compared to its average volume of 349,700. Bausch Health Companies has a twelve month low of C$7.56 and a twelve month high of C$15.43. The firm has a market cap of C$4.48 billion, a price-to-earnings ratio of -5.51, a P/E/G ratio of 0.21 and a beta of 0.83. The business’s fifty day moving average price is C$12.65 and its 200-day moving average price is C$11.10. The company has a debt-to-equity ratio of 7,583.76, a quick ratio of 0.58 and a current ratio of 1.30.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada boosted their target price on Bausch Health Companies from C$8.00 to C$9.00 and gave the company a “sector perform” rating in a report on Friday, February 23rd.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.